When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
DOVA - FDA OKs Dova's Doptelet for low blood platelets in ITP patients; shares up 21% premarket
Dova Pharmaceuticals Inc.
The FDA approves Dova Pharmaceuticals' (NASDAQ:DOVA) supplemental marketing application for DOPTELET (avatrombopag) to include treatment of thrombocytopenia (low blood platelets) in adult patients with chronic immune thrombocytopenia who have failed to sufficiently respond to previous therapy.
More news on: Dova Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,